These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19136239

  • 1. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
    Korsgaard J, Ledet M.
    Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 3. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 4. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T, Adachi M.
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
    Beeh KM, Beier J, Kornmann O, Wiewrodt R, Buhl R, SAS 40011-Studiengruppe.
    Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
    [Abstract] [Full Text] [Related]

  • 6. Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis.
    Foster JM, Aucott L, van der Werf RH, van der Meijden MJ, Schraa G, Postma DS, van der Molen T.
    Respir Med; 2006 Aug; 100(8):1318-36. PubMed ID: 16442275
    [Abstract] [Full Text] [Related]

  • 7. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 8. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 9. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [Abstract] [Full Text] [Related]

  • 10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 11. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S.
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [Abstract] [Full Text] [Related]

  • 12. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD, Man SF.
    Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate use of inhaled short acting beta-agonists and its association with patient health status.
    Hong SH, Sanders BH, West D.
    Curr Med Res Opin; 2006 Jan; 22(1):33-40. PubMed ID: 16393428
    [Abstract] [Full Text] [Related]

  • 14. [Long-acting beta-2 agonists. An attempted response to various questions which can be posed by pneumonologists].
    Vervloet D, Magnan A.
    Rev Mal Respir; 1998 Feb; 15(1):25-31. PubMed ID: 9551511
    [Abstract] [Full Text] [Related]

  • 15. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA, Tashkin DP.
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [Abstract] [Full Text] [Related]

  • 16. Is there a problem with inhaled long-acting beta-adrenergic agonists?
    Nelson HS.
    J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
    [Abstract] [Full Text] [Related]

  • 17. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
    Beeh KM, Beier J.
    Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
    [Abstract] [Full Text] [Related]

  • 18. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
    Hui KP.
    Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID, Cloosterman SG, Folgering HT, van den Elshout FJ, van Weel C, van Schayck CP.
    Am J Respir Crit Care Med; 2001 Sep 01; 164(5):764-9. PubMed ID: 11549530
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D, Glaum M, Lockey R.
    Expert Opin Drug Metab Toxicol; 2009 Aug 01; 5(8):933-40. PubMed ID: 19619072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.